What does Klinisch Laboratorium Maenhout do?

Klinisch Laboratorium Maenhout is a healthcare practice in Waregem. Private Limited, started on 1 January 1980, 1 establishment.

What is the address of Klinisch Laboratorium Maenhout?

The registered office of Klinisch Laboratorium Maenhout is located at Roger Vansteenbruggestraat 64 box 1, 8790 Waregem.

Is Klinisch Laboratorium Maenhout still active?

Yes. According to the CBE (30 October 2026) Klinisch Laboratorium Maenhout is active, legal situation “Normale toestand”, started on 1 January 1980.

Is Klinisch Laboratorium Maenhout registered on Peppol?

Yes, Klinisch Laboratorium Maenhout is registered on the Peppol network with ID 0208:0420196971.

What is the enterprise number of Klinisch Laboratorium Maenhout?

The enterprise number of Klinisch Laboratorium Maenhout is BE0420196971.

When was Klinisch Laboratorium Maenhout founded?

Klinisch Laboratorium Maenhout was founded on 1 January 1980.

Who are the directors of Klinisch Laboratorium Maenhout?

According to the 2025 annual accounts, the directors of Klinisch Laboratorium Maenhout are: METALAB BV, DE ARK BV.

Is Klinisch Laboratorium Maenhout a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1980; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Klinisch Laboratorium Maenhout make in 2025?

Klinisch Laboratorium Maenhout posted a profit after taxes of € 384,582 in financial year 2025.

What is the revenue of Klinisch Laboratorium Maenhout?

As a small company, Klinisch Laboratorium Maenhout is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,883,973.

How much does an employee at Klinisch Laboratorium Maenhout earn?

The average wage cost per full-time employee at Klinisch Laboratorium Maenhout was € 57,800 in 2025: staff costs of € 1.8 million for 31.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Klinisch Laboratorium Maenhout have?

According to the 2025 annual accounts, Klinisch Laboratorium Maenhout has 31.9 full-time equivalents (FTE).

Does Klinisch Laboratorium Maenhout have a website?

Yes, Klinisch Laboratorium Maenhout has a website at labomaenhout.be.

Klinisch Laboratorium Maenhout (Private Limited)

Dossier Klinisch Laboratorium Maenhout, printed on 30 October 2026 from databakkes.be/en/0420196971/klinisch-laboratorium-maenhout. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Klinisch Laboratorium Maenhout from Waregem, company number BE0420196971, closed financial year 2025 with a result of € 384,582 after tax. For that financial year Klinisch Laboratorium Maenhout recorded a gross margin of € 2.9 million and equity of € 4 million. Compared with financial year 2024, the result moved from € 299,784 to € 384,582. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 24, 2026.

What it is worth Growing

€ 4 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 384,582

▲ 28% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 104,334

▼ 83% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 3.8 million.

People and assets in 2025

Full-time equivalents

31.9

▲ 6.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.8 million

▲ 19% vs 2024

€ 57,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 228,085

▲ 3% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.2 million

▲ 20% vs 2024

€ 274,700 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 188,206

▼ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 179,618

▲ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 4,148,588 Gross margin 2022: € 4,148,588 First fiscal year in the series	€ 3,020,879 Gross margin 2023: € 3,020,879 ▼ 27% vs 2022 (€ 4,148,588) Unfavourable step	€ 2,390,316 Gross margin 2024: € 2,390,316 ▼ 21% vs 2023 (€ 3,020,879) Unfavourable step	€ 2,883,973 Gross margin 2025: € 2,883,973 ▲ 21% vs 2024 (€ 2,390,316) Favourable step	▲ 21%
Profit after taxes	€ 1,491,424 Profit after taxes 2022: € 1,491,424 First fiscal year in the series	€ 753,455 Profit after taxes 2023: € 753,455 ▼ 49% vs 2022 (€ 1,491,424) Unfavourable step	€ 299,784 Profit after taxes 2024: € 299,784 ▼ 60% vs 2023 (€ 753,455) Unfavourable step	€ 384,582 Profit after taxes 2025: € 384,582 ▲ 28% vs 2024 (€ 299,784) Favourable step	▲ 28%
Equity	€ 4,806,736 Equity 2022: € 4,806,736 First fiscal year in the series	€ 4,360,192 Equity 2023: € 4,360,192 ▼ 9% vs 2022 (€ 4,806,736) Unfavourable step	€ 3,659,975 Equity 2024: € 3,659,975 ▼ 16% vs 2023 (€ 4,360,192) Unfavourable step	€ 4,044,558 Equity 2025: € 4,044,558 ▲ 11% vs 2024 (€ 3,659,975) Favourable step	▲ 11%
Total debts	€ 3,569,699 Total debts 2022: € 3,569,699 First fiscal year in the series	€ 2,821,321 Total debts 2023: € 2,821,321 ▼ 21% vs 2022 (€ 3,569,699) Favourable step	€ 2,071,318 Total debts 2024: € 2,071,318 ▼ 27% vs 2023 (€ 2,821,321) Favourable step	€ 1,559,664 Total debts 2025: € 1,559,664 ▼ 25% vs 2024 (€ 2,071,318) Favourable step	▼ 25%
Cash	€ 1,806,199 Cash 2022: € 1,806,199 First fiscal year in the series	€ 1,217,811 Cash 2023: € 1,217,811 ▼ 33% vs 2022 (€ 1,806,199) Unfavourable step	€ 616,878 Cash 2024: € 616,878 ▼ 49% vs 2023 (€ 1,217,811) Unfavourable step	€ 104,334 Cash 2025: € 104,334 ▼ 83% vs 2024 (€ 616,878) Unfavourable step	▼ 83%
Land & buildings	€ 788,780 Land & buildings 2022: € 788,780 First fiscal year in the series	€ 823,735 Land & buildings 2023: € 823,735 ▲ 4% vs 2022 (€ 788,780) Unchanged	€ 799,647 Land & buildings 2024: € 799,647 ▼ 3% vs 2023 (€ 823,735) Unchanged	€ 756,175 Land & buildings 2025: € 756,175 ▼ 5% vs 2024 (€ 799,647) Unchanged	▼ 5%
Retained profit	€ 4,556,736 Retained profit 2022: € 4,556,736 First fiscal year in the series	€ 4,110,192 Retained profit 2023: € 4,110,192 ▼ 10% vs 2022 (€ 4,556,736) Unfavourable step	€ 3,409,975 Retained profit 2024: € 3,409,975 ▼ 17% vs 2023 (€ 4,110,192) Unfavourable step	€ 3,794,558 Retained profit 2025: € 3,794,558 ▲ 11% vs 2024 (€ 3,409,975) Favourable step	▲ 11%
Dividend	€ 1,500,000 Dividend 2022: € 1,500,000 First fiscal year in the series	€ 1,200,000 Dividend 2023: € 1,200,000 ▼ 20% vs 2022 (€ 1,500,000) Unchanged	€ 1,000,000 Dividend 2024: € 1,000,000 ▼ 17% vs 2023 (€ 1,200,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 1,000,000) Unchanged	▼ 100%
Bank debt	€ 1,656,803 Bank debt 2022: € 1,656,803 First fiscal year in the series	€ 1,167,859 Bank debt 2023: € 1,167,859 ▼ 30% vs 2022 (€ 1,656,803) Favourable step	€ 989,240 Bank debt 2024: € 989,240 ▼ 15% vs 2023 (€ 1,167,859) Favourable step	€ 1,187,040 Bank debt 2025: € 1,187,040 ▲ 20% vs 2024 (€ 989,240) Unfavourable step	▲ 20%
Balance sheet total	€ 8,376,435 Balance sheet total 2022: € 8,376,435 First fiscal year in the series	€ 7,181,512 Balance sheet total 2023: € 7,181,512 ▼ 14% vs 2022 (€ 8,376,435) Unchanged	€ 5,731,294 Balance sheet total 2024: € 5,731,294 ▼ 20% vs 2023 (€ 7,181,512) Unchanged	€ 5,604,222 Balance sheet total 2025: € 5,604,222 ▼ 2% vs 2024 (€ 5,731,294) Unchanged	▼ 2%
Employees (FTE)	26.6 Employees (FTE) 2022: 26.6 First fiscal year in the series	24 Employees (FTE) 2023: 24 ▼ 2.6 vs 2022 (26.6) Unchanged	25.3 Employees (FTE) 2024: 25.3 ▲ 1.3 vs 2023 (24) Unchanged	31.9 Employees (FTE) 2025: 31.9 ▲ 6.6 vs 2024 (25.3) Unchanged	▲ 6.6

Key figures of Klinisch Laboratorium Maenhout, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Klinisch Laboratorium Maenhout?

What happened at Klinisch Laboratorium Maenhout in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 24, 2026 New annual accounts for financial year 2025: profit of € 384,582 (▲ 28% vs 2024). Source: NBB ↗
2011 METALAB BV became a director. NBB
Jan 1, 1980 New establishment in Waregem. KBO
Jan 1, 1980 Start of the company according to the CBE. KBO

In short

From € 1.5 million profit in 2022 to € 384,582 profit in 2025.

Paid € 982,003 in corporate taxes since 2022.

Best year ever: 2022, with € 1.5 million profit.

On average € 90,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DE ARK 100%

The stake of DE ARK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Klinisch Laboratorium Maenhout

Vital Signs 44%

Behind Klinisch Laboratorium Maenhout are METALAB BV and DE ARK BV. The shares are held by DE ARK (100%). It owns 44% of Vital Signs itself.

Directors

According to the 2025 annual accounts

METALAB BV

Director · represented by Patrick Maenhout

since 2011

DE ARK BV

Director · represented by Thomas Maenhout

Also active at: LabCare Plus, MEDISCH LABORATORIUM

Shareholders

DE ARK

100%

Participations

Vital Signs

44%

Establishments

Establishment units

Physical locations of this company

Registered office

Roger Vansteenbruggestraat 64 box 1

8790 Waregem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Vital Signs same network

€ -37,603 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS labomaenhout.be

Technologies

Google AnalyticsGoogle FontsNginxjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages NL

Features

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0420.196.971

VAT number

BE 0420.196.971

Registered office

Roger Vansteenbruggestraat 64 bus 1, 8790 Waregem

Names & denominations

Klinisch Laboratorium Maenhout

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1980

Peppol

Active · Active since 18 Aug 2025

Contact

labomaenhout.be

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

Klinisch Laboratorium Maenhout

Financials

What happened to Klinisch Laboratorium Maenhout?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions